The increasing demand for peripheral artery disease treatment, rapid advancements in the angioplasty devices market, and growing adoption of the vascular stents market are transforming the management of vascular disorders worldwide. Peripheral artery disease (PAD) is a circulatory condition caused by narrowed or blocked arteries, commonly affecting blood flow to the lower extremities. Rising cases of diabetes, obesity, hypertension, and cardiovascular disorders are increasing the global burden of PAD and creating significant demand for advanced diagnostic and treatment solutions. These trends are driving the growth of the Peripheral Artery Disease Market, supported by innovations in minimally invasive procedures, next-generation vascular devices, and improved patient management approaches. According to Polaris Market Research.

The global peripheral artery disease market size was valued at USD 5.11 billion in 2024 and is projected to expand at a CAGR of 7.5% from 2025 to 2034. The market is expected to reach USD 5.49 billion in 2025 and further grow to approximately USD 10.53 billion by 2034.

Growing Demand for Peripheral Artery Disease Treatment

The rising prevalence of PAD is increasing the need for effective peripheral artery disease treatment options that improve blood circulation, reduce symptoms, and prevent severe complications. Treatment strategies vary depending on disease severity and may include lifestyle modifications, medications, minimally invasive procedures, and surgical interventions.

Common treatment approaches include:

• Angioplasty procedures
• Peripheral vascular stenting
• Atherectomy procedures
• Drug therapies
• Bypass surgeries
• Exercise-based rehabilitation programs

The growing adoption of minimally invasive endovascular treatments is significantly improving patient outcomes by reducing recovery time, lowering procedural risks, and providing effective restoration of blood flow. Advances in imaging technologies and catheter-based interventions are also supporting early diagnosis and targeted treatment of PAD.

Expansion of the Angioplasty Devices Market

The angioplasty devices market is experiencing strong growth due to the increasing preference for minimally invasive vascular procedures. Angioplasty devices help restore blood flow by widening narrowed arteries and are widely used in PAD treatment.

Key angioplasty technologies include:

• Balloon angioplasty catheters
• Drug-coated balloons
• Peripheral dilation balloons
• Atherectomy-assisted angioplasty systems

Drug-coated balloon technology has gained attention due to its ability to reduce restenosis risks and improve long-term treatment outcomes. Continuous innovation in catheter design, improved device flexibility, and enhanced delivery systems are further increasing the adoption of angioplasty procedures.

The growing number of patients requiring vascular interventions, combined with technological improvements, is expected to create new opportunities within the angioplasty devices market.

Growth of the Vascular Stents Market

The vascular stents market plays a crucial role in PAD management by providing structural support to maintain artery openness after intervention. Stents are increasingly used in patients with complex arterial blockages where maintaining long-term vessel patency is essential.

Modern vascular stent technologies include:

• Self-expanding stents
• Balloon-expandable stents
• Drug-eluting stents
• Bioresorbable stent technologies

The development of advanced stent designs is focused on improving flexibility, reducing complications, and enhancing durability. Innovations such as drug-releasing and biodegradable stents are helping address limitations associated with traditional permanent implants.

Increasing adoption of peripheral stents in femoropopliteal and below-the-knee interventions is expected to support market expansion in the coming years.

Key Factors Driving the Peripheral Artery Disease Market

Several factors are contributing to the expansion of the global Peripheral Artery Disease Market:

• Rising prevalence of diabetes and hypertension
• Increasing aging population
• Growing incidence of cardiovascular diseases
• Rising demand for minimally invasive treatments
• Technological advancements in vascular devices
• Improved awareness of early PAD diagnosis
• Expansion of healthcare infrastructure

Diabetes and metabolic disorders are among the major risk factors associated with PAD. As these conditions continue to increase globally, healthcare systems are focusing on early detection and effective vascular management strategies.

Discover the Complete Report Here:

https://www.polarismarketresearch.com/industry-analysis/peripheral-artery-disease-market

Key Players

• Abbott
• AngioDynamics
• B. Braun SE
• Bayer AG
• BD
• Biotronik
• Boston Scientific Corporation
• Cardinal Health
• Endologix LLC
• iVascular
• Johnson & Johnson
• Koninklijke Philips N.V.
• Medtronic
• Terumo Corporation

Regional Market Outlook

North America currently holds a significant share of the Peripheral Artery Disease Market, supported by advanced healthcare infrastructure, high adoption of minimally invasive procedures, strong reimbursement systems, and increasing awareness of vascular health. The United States represents a major contributor due to the high prevalence of diabetes, obesity, and cardiovascular disorders.

Europe is also witnessing steady growth due to increasing investments in healthcare technology, rising adoption of advanced vascular devices, and growing demand for effective PAD management solutions.

The Asia-Pacific region is expected to experience significant growth during the forecast period. Rising healthcare expenditure, improving access to advanced treatments, increasing disease awareness, and expanding medical infrastructure are driving market opportunities across emerging economies.

Future Outlook

The future of the Peripheral Artery Disease Market will be shaped by continuous innovation in vascular technologies, increasing adoption of minimally invasive treatments, and growing emphasis on preventive cardiovascular care. The development of advanced angioplasty devices, next-generation vascular stents, and personalized treatment approaches will continue to improve PAD management.

As healthcare providers focus on reducing complications and improving quality of life for patients, demand for effective peripheral artery disease solutions is expected to increase.

Conclusion

The growing need for peripheral artery disease treatment, advancements in the angioplasty devices market, and increasing adoption of the vascular stents market are driving significant growth within the Peripheral Artery Disease Market. Supported by rising disease prevalence, technological innovation, and increasing demand for minimally invasive vascular procedures, the market is positioned for sustained expansion. Continued advancements in vascular care technologies will further enhance treatment outcomes and improve patient access to effective PAD management solutions worldwide.

More Trending Latest Reports By Polaris Market Research:

Internet Of Things (Iot) In Healthcare Market

Mortuary Equipment Market

Anorexiants Market

US companion diagnostics (CDx) development market

Inflammatory Bowel Disease (Ibd) Market

Dendritic Cell Cancer Vaccine Market

Clinical Trial Biorepository & Archiving Solutions Market

Tangential Flow Filtration Market